in 2021 found that the prognosis of glioblastoma (GBM) can be determined by seven differentially expressed genes (DEGs) 47, namely CLEC5A, HOXC6, HOXA5, CCL2, GPRASP1, BSCL2, and PTX3. Here, HOXA5 is linked to glioblastoma.